Your browser doesn't support javascript.
loading
Treatment of refractory sclerodermatous chronic graft-versus-host disease with intravenous lidocaine infusions.
Phipps, C; Lupo-Stanghellini, M T; Flowers, M E D.
Affiliation
  • Phipps C; 1] Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA [2] Department of Haematology, Singapore General Hospital, Singapore, Singapore.
  • Lupo-Stanghellini MT; 1] Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA [2] Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy.
  • Flowers ME; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Bone Marrow Transplant ; 49(2): 315-6, 2014 Feb.
Article in En | MEDLINE | ID: mdl-24076547

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Scleroderma, Localized / Graft vs Host Disease / Anesthetics, Local / Lidocaine Type of study: Observational_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2014 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Scleroderma, Localized / Graft vs Host Disease / Anesthetics, Local / Lidocaine Type of study: Observational_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2014 Document type: Article Affiliation country: